Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
The Rett syndrome is a progressive neurodevelopmental disorder and one of the most common causes of mental retardation in females. Because males have a different chromosome combination from females, most males with Rett syndrome die before birth or in early infancy. It was not until 1999 that it was discovered that the Rett syndrome is caused by mutations in the gene encoding the methyl-CpG-binding protein 2 (MeCP2). MeCP2 belongs to a class of proteins called Intrinsically Disordered Proteins (IDPs). In contrast with globular proteins, IDPs do not have a well-defined secondary or tertiary structure and can adopt a wide range of conformations. This makes their structural characterization a challenge. We have studied MeCP2 and determined that there currently is no single method that can do it. However, combination of ABF and our metadynamics-based methods appears to offer the possibility to resolve the problem. If successful, this study would lead to a scientific breakthrough, helping us to identify the effects of reported mutations and potentially bring us one step closer to develop a treatment that may improve the lives of those diagnosed with Rett syndrome.
Mikko Karttunen
Institut de Biologie Physico-Chimique
Physics
Life Sciences (not health); Pharmaceuticals; Biotechnology
Western University
Globalink Research Award
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find ProjectsThe strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.